Literature DB >> 8063919

Coping and communication among parents and children with human immunodeficiency virus and cancer.

M S Hardy1, F D Armstrong, D K Routh, J Albrecht, J Davis.   

Abstract

Coping strategies and communication of three groups of 20 preschool children and their parents were compared. One group was composed of children infected with the human immunodeficiency virus (HIV) who displayed clinical symptoms of the disease; the second group was composed of children diagnosed with cancer; and the third group was composed of healthy children. Results indicated that the parents of children with life-threatening illnesses reported greater degrees of wishful thinking than did control subjects. Furthermore, parents of children with HIV reported more wishful thinking than did parents of children with cancer. Finally, significantly more children with cancer were aware of their diagnosis than were children with HIV. The findings in this study suggest coping and communication difficulties for parents and children with HIV.

Entities:  

Mesh:

Year:  1994        PMID: 8063919

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  3 in total

Review 1.  Disclosure of an HIV diagnosis to children: history, current research, and future directions.

Authors:  Lori Wiener; Claude Ann Mellins; Stephanie Marhefka; Haven B Battles
Journal:  J Dev Behav Pediatr       Date:  2007-04       Impact factor: 2.225

2.  Cross Sectional Characterization of Factors Associated with Pediatric HIV Status Disclosure in Southern Ethiopia.

Authors:  Birkneh Tilahun Tadesse; Byron Alexander Foster; Yifru Berhan
Journal:  PLoS One       Date:  2015-07-13       Impact factor: 3.240

3.  Tensions in Communication between Children on Antiretroviral Therapy and Their Caregivers: A Qualitative Study in Jinja District, Uganda.

Authors:  Phoebe Kajubi; Susan Reynolds Whyte; David Kyaddondo; Anne Ruhweza Katahoire
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.